Correlogic Assay Is Future Adjunct To Prostate Cancer Detection, NCI Says
This article was originally published in The Gray Sheet
Executive Summary
Proteomic pattern analysis may help reduce the number of unnecessary prostate biopsies, according to the National Cancer Institute
You may also be interested in...
Correlogic Proteome Quest Ovarian Cancer Assay Propels Funding Call On Hill
Sponsors of a House resolution seeking accelerated research and health insurance coverage for a specific type of ovarian cancer test will try to include language from the legislation in the HHS appropriations conference report for fiscal 2003
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.